Neurodegenerative Disease Industry 2026
View Trends, Analysis and Statistics.
1 000+ Neurodegenerative Disease Industry reports covering 200 countries — revenue data, market shares and forecast 2026-2030.
Global Neurodegenerative Disease Industry 2026‑2030
Global neurodegenerative disease market to surpass $62B by 2030 at 7.4% CAGR. Production data and launch activity from leading pharma worldwide. Covers market trends and economic analysis across 2026-2030.
North American Neurodegenerative Disease Industry 2026‑2030
North America holds 42% of the global neurodegenerative disease market. Tracks product launches and partnerships among top regional players. Segment forecasts and pipeline coverage for the 2026-2030 period.
US Neurodegenerative Disease Industry 2026‑2030
US neurodegenerative disease market valued at $18.5B, leading global demand. Tracks partnerships among Biogen, Eli Lilly and emerging biotech firms. Covers care infrastructure and pipeline developments through 2030.
European Neurodegenerative Disease Industry 2026‑2030
European neurodegenerative disease market forecast at $15.8B by 2030. M&A and production data across leading EU pharma manufacturers. Market trends and infrastructure analysis spanning 2026-2030.
Asian Neurodegenerative Disease Industry 2026‑2030
Asia neurodegenerative disease market to grow at 8.2% CAGR through 2030. Market share analysis of top players including regional pharma leaders. Includes market size, product launches and production data for 2026-2030.
Any questions? Get in touch with Emilie
[email protected]
ReportLinker Rating
96%
of our customers give us a high rating on Trustpilot and G2 platforms